Point72 Asset Management's 9.9% Stake in iBio, Inc.

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have filed a Schedule 13G indicating a 9.9% beneficial ownership in iBio, Inc. The ownership includes 14,280,000 shares of common stock issuable upon exercise of warrants, subject to a 9.99% blocker. The filing is made jointly under Rule 13d-1(k) of the Securities Exchange Act of 1934. The reporting persons have shared voting and dispositive power over the shares, with no sole voting or dispositive power. The filing certifies that the securities were not acquired to influence the control of the issuer.